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ABSTRACT
Recent studies suggest that patients with type 2diabetes mellitus are atincreased riskof fracture, possibly because hyperinsulinemia isa
risk factor for low bone mineral density, which may in turn be a consequence of a lipotoxic effect of visceral and/or intramuscular fat on
bone. In the current study, we investigated whether insulin plays a role in cortical bone development by performing a cross-sectional
study based on the Avon Longitudinal Study of Parents and Children (ALSPAC), where we examinedassociations between fasting insulin
levels and peripheral quantitative computed tomography (pQCT) parameters as assessed at the mid-tibia in 2784 boys and girls with a
mean age 15.5 years. In particular, we wished to examine whether associations that we observed were independent of body
composition, including intramuscular fat. We found that insulin was inversely related to cortical bone mineral density (BMDC) after
adjustment for age and after further adjustment for height, muscle cross-sectional area (MCSA), subcutaneous fat (SAT), and muscle
density(MD),whichisinverselyrelatedtointramuscularfat( 0.018,95%confidenceinterval[CI] 0.030, 0.006,p<0.0001).Insulinwas
positively related to periosteal circumference (PC) after adjusting for age (0.015, 95% CI 0.003, 0.027, p¼0.015; beta¼change per 50%
increaseininsulin),butthischangedtoaninverseassociationafteradditionaladjustmentforheightandbodycomposition( 0.013,95%
CI  0.022,  0.003, p¼0.008). Path analyses revealed inverse associations between insulin and PC via a direct pathway ( 0.012, 95% CI
 0.022,  0.003, p¼0.01) and via MD ( 0.002, 95% CI  0.004,  0.001, p¼0.0004), and positive associations between insulin and PC via
SAT (0.013, 95% CI 0.009, 0.016, p<0.0001) and MCSA (0.015, 95% CI 0.010, 0.020, p<0.0001). In conclusion, we found an inverse
relationship between insulin and PC via intramuscular fat, suggesting a lipotoxic effect on bone. However, an inverse association
betweeninsulinandbothPCandBMDCpersistedafteradjustingforallbody compositionvariables, suggestinginsulinalsoactstoinhibit
bone development via additional pathways yet to be elucidated.  2012 American Society for Bone and Mineral Research.
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Introduction
I
nsulin resistance, the prevalence of which is increasing in
adolescents alongside childhood obesity,
(1) is associated with
several long-term complications of type 2 diabetes mellitus (DM)
including an increased risk of fractures, particularly at the hip.
(2)
Although bone mineral density (BMD) as measured by dual-
energyX-ray absorptiometry(DXA)isinverselyrelatedtofracture
risk in the general population,
(3) this relationship appears to be
alteredintype2DM,exemplifiedbyfindingsfromtheRotterdam
study in which subjects with type 2 DM had an increased risk of
nonvertebral fractures despite having a higher lumbar spine and
femoral neck BMD.
(4) Consistent with the latter observation,
several cross-sectional studies have found that BMD is also
increased in patients with metabolic syndrome, which is
associated with obesity, insulin resistance, and hyperinsuline-
mia.
(5–9) However, after adjustment for body mass index (BMI),
BMD has frequently been found to be reduced in those with
metabolic syndrome, particularly in males,
(5,7–9) suggesting that,
if anything, insulin may exert a negative influence on BMD once
associations with BMI are taken into account.
Lipotoxicity describes the deposition of fat within the liver and
skeletal muscles in association with obesity, which has been
implicated in the pathogenesis of insulin resistance and other
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610components of the metabolic syndrome.
(10) Any tendency for
lipotoxicity to adversely affect bone might explain the negative
association between metabolic syndrome and BMD in the studies
describedabove, ontheassumptionthatadjustmentfor BMI does
not fully account for possible influences of visceral or intramus-
cular fat deposition. Consistent with this suggestion, visceral fat
deposition, as assessed by computed tomography (CT) or
magnetic resonance imaging (MRI), has been suggested to
exert an adverse influence on BMD.
(11–14) The latter studies
included two reports based on adolescent populations, suggest-
ing that insulin also has the potential to impair childhood
skeletal development via a lipotoxic pathway. Consistent with
this suggestion, in the study of adolescents by Pollock and
colleagues,
(11) HOMA-IR, a measure of insulin resistance, was also
found to be inversely related to bone mineral content (BMC).
Moreover, an inhibitory influence of visceral fat on bone was
suggested to be on the same pathway as insulin because the
negativeassociationbetweenvisceraladiposetissueandBMCwas
no longer observed when HOMA-IR was included in the model.
One of the limitations in dissecting out relationships between
insulin resistance, BMC, and fat deposition is the difficulty in
adjusting for body size and stature, particularly in children where
differences are exaggerated by variation in age and maturational
status.
(15) Peripheral quantitative computed tomography (pQCT)
overcomes this limitation by enabling effects on bone size to be
distinguished from those on other parameters such as cortical
bone density and the amount of trabecular bone. We recently
used this method in the Avon Longitudinal Study of Parents and
Children (ALSPAC) to explore relationships between body
composition and bone geometry as measured by DXA and
pQCT, respectively, observing that total body fat and lean mass
both make strong independent contributions to cortical bone
development.
(16) pQCT has also been used to evaluate possible
adverse effects of lipotoxicity on skeletal development, based on
measurementofintramuscular fat. Forexample, inarecent study
of 444 girls aged 9 to 12 years, muscle density as measured
by pQCT was positively related with cortical bone mineral
density (BMDC), consistent with a negative association with the
extent of intramuscular fat.
(17)
In the current study, we explored the role of insulin in skeletal
development in childhood by using pQCT to examine cross-
sectional relationships between fasting insulin levels and indices
of cortical bone development in adolescents from ALSPAC, in
whom both these measures had been obtained at age 15 years.
In particular, we wished to determine: 1) whether fasting insulin
is related to cortical bone parameters at this age, 2) whether any
relationships that we find are independent not only of lean mass
and fat mass but also of intramuscular fat as reflected by muscle
density, and 3) whether these associations show any evidence of
gender specificity, in light of previous observations that after
adjusting for BMI, BMD is preferentially reduced in male subjects
with the metabolic syndrome.
Materials and Methods
Study population
ALSPAC is a geographically based birth cohort study investigat-
ing factors influencing the health, growth, and development
of children. All pregnant women residing within a defined
part of the former county of Avon in South West England
with an expected date of delivery between April 1991 and
December 1992 were eligible for recruitment, of whom 14,541
were enrolled (http://www.alspac.bristol.ac.uk).
(18) Ethical ap-
proval was obtained from the ALSPAC Law and Ethics committee
andrelevant local ethicscommittees. Data inALSPAC iscollected
by self-completion postal questionnaires sent to parents, by
linkage to computerized records, by abstraction from medical
records, and from examination of the children at research clinics.
Bone and anthropometric variables
BMCC and cortical bone mineral density (BMDC) of the mid (50%
from the distal endplate) right tibia were obtained using a
Stratec XCT2000L (Stratec, Pforzheim, Germany) during the age
15.5-year research clinic to which all ALSPAC participants were
invited as part of a study investigating the effects of physical
activity on cortical bone as previously published.
(19) Periosteal
circumference (PC) and endosteal circumference (EC) were
derived using a circular ring model. Strength strain index (SSI)
wascalculated according tothe Stratecuser’smanual.
(20)Cortical
bone was defined using a threshold above 650mg/cm
3. Muscle
cross-sectional area (MCSA), muscle density, and subcutaneous
fat area (SAT) were obtained after image processing with a set of
four convoluted image filters, as described in the Stratec user’s
manual.
(20) In brief, image convolution processes the original
image I and creates I’; if a second filter is applied, I’ is processed
and creates I’’ and so on. Using the Stratec large soft tissue filters
(F03F05F05¼3 3[  500, 500mg/cm
3], 5 5[  500, 300mg/
cm
3]), the image was sequentially smoothed three times and
total limb cross-sectional area (CSA) was calculated. A subse-
quent filter was applied to remove all fat density voxels from the
image (F07¼[ 500, 30mg/cm
3]), and total fat-free limb CSA
was calculated. MCSA was calculated by subtracting total bone
areafromthefat-freetotallimbCSA.WithinSubjectcoefficientof
variation for pQCT parameters are displayed in parentheses:
tibial length (4.04%), BMCC (2.71%), BMDC (1.29%), PC (1.58%), EC
(4.03%), MCSA (6.73%), MDEN (5.24%), SAT (4.86%), SSI (3.72%).
Height was measured using a Harpenden stadiometer (Holtain
Ltd., Crymych, UK). All densitometric and anthropometric
measures were taken in the 15.5-year research clinic.
Confounding variables
Puberty was assessed using a self-completed Tanner stage
questionnaire (pubichairdomain)atameanageof14.8years.
(21)
Social economic position was derived using the registrar general
social class classification and maternal highest educational
attainment.
(22)
Insulin measurement
Participants were asked to fast overnight (for those attending in
the morning) or for a minimum of 6hours for those attending
after lunch. Blood plasma samples (EDTA) were immediately
spun and frozen at  808C. Measurements were assayed
shortly (3 to 9 months) after samples were taken with no
previous freeze-thaw cycles. Insulin was measured by an
ultrasensitive ELISA (Mercodia, Uppsala, Sweden) automated
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with proinsulin. Its sensitivity was0.07mU/L, and inter- and intra-
assay coefficients of variation were <6%.
Statistical analysis
Descriptive statistics are presented as means, standard devia-
tions, and interquartile cut-points. Insulin, muscle density, and
SAT were positively skewed and subsequently loge transformed
to aid model specification. Ordinary least squares (OLS) linear
regression was used to investigate associations between insulin
and pQCT variables after minimal adjustment (age only) and
adjustment for height, MCSA, muscle density, and SAT. Because
of the strong association between EC and PC, analyses with EC
were adjusted for PC. Models with BMDC were analyzed with and
without adjustment for EC and PC because of relationships
between BMDC and cortical bone size. Path analyses were
conducted to explore the relationship between insulin and PC.
The direct association was obtained from a multivariate linear
regression of exposure (ie, insulin) on outcome (ie, PC) adjusted
for confounders. Indirect associations (via MCSA, muscle density,
and SAT) were calculated by multiplying the association of
exposure on intermediate adjusted for confounders, with the
association of the intermediate on outcome adjusted for
confounders. The total effect is the sum of the direct and
indirect associations.
(23) Path coefficients were calculated using
a nonparametric bootstrap procedure, stratified by sex and
sampled with replacement for 10,000 iterations. Sensitivity
analyses were conducted, adjusted for pubertal status, maternal
education, and maternal and paternal social class. Data are
assumed to be missing at random, and complete case analysis
wasperformedinallcases.AllanalyseswereconductedinSTATA
11.1 MP (StataCorp, College Station, TX, USA).
Results
The study included 1344 boys and 1440 girls (see Fig. 1 for
recruitment flow). As shown in Table 1, fasting insulin levels were
higher in girls. As expected, boys had greater lean mass as
reflected by greater MSCA, whereas fat mass as reflected by SAT
was greater in girls. In contrast, muscle density was similar in
boys and girls. Boys were taller and had greater inner and outer
circumferences of tibial cortical bone, as reflected by EC and PC,
respectively. BMDC was greater in girls, whereas BMCC was
greaterinboys,reflectingthefactthatvariationinthisparameter
is largely determined by differences in cortical bone size. A total
of 729 boys and 839 girls were available with information on
socioeconomic variables and pubertal status (Supplemental
Table S1), which revealed that 84% of boys and 90% of girls were
in advanced puberty as defined by Tanner stage IV/V.
The relationship between fasting insulin and indices of body
composition as assessed by pQCT were explored in analyses
adjusted for age and height (Table 2). Insulin was positively
related to both MSCA and SAT. The relationship between insulin
and SAT was stronger in boys (p<0.05 for sex interaction).
Insulin was inversely related to muscle density, in keeping with a
positive association with intramuscular fat, with evidence that
this association was also stronger in boys (p¼0.09 for sex
interaction; muscle densitywasalsoadjustedforMCSAinviewof
the positive relationship between these two parameters,
independent of height). Equivalent results were obtained when
results were analyzed in the subset of subjects with available
information on socioeconomic status and puberty followed by
adjustment for these variables (Supplemental Table S2).
Relationships between insulin and pQCT parameters were
subsequently examined in minimally adjusted models (age) and
more completely adjusted models (age, height, MSCA, SAT,
and muscle density) (Table 3). In minimally adjusted analyses,
insulin was positively related to PC. There was some evidence
that this relationship was stronger in girls, in whom beta
coefficients were more than twice that in boys, although the
p value for sex interaction was >0.1. Conversely, in our more
completely adjusted model, insulin was inversely related to PC,
with a suggestion that this relationship was stronger in boys
based on beta coefficients, although the p value for sex
interaction was again >0.1. Insulin was unrelated to EC in either
minimal or more completely adjusted analyses (EC was adjusted
for PC in all models, so as to provide an estimate of cortical
thickness). Insulin was inversely related with BMDC, in both
minimal and more completely adjusted analyses. These included
further analyses in which associations were adjusted not only for
age and body composition but also for PC and EC, in view of
associations between the latter parameters and BMDC.
(16) There
was also evidence that the inverse association between insulin
and BMDC was stronger in boys, in whom beta coefficients were
approximately twice that in girls, although the p value for sex
interaction was  0.2. Similar results for BMCC and SSI were
Live Births 
(Singleton & Multiple) 
N=14,062
Age 15.5 Fasting Insulin 
N=3,523
Age 15.5 pQCT & Anthropometry 
N=4,502
Minimal Adjusted Analyses 
(Age + Sex adjusted) 
N=2,784
Initial Recruitment 
N=14,541
Adjusted Analyses 
(Minimal + Height + Body Composition) 
N=2,784
Sensitivity Analyses 
(Adjusted + Maternal education + Maternal / 
Paternal Social Class + Pubertal Stage) 
N=1,568
Fig. 1. Diagramshowingthesourceofsubjectsformainanalysesandfor
sensitivityanalysesbasedonthesubsetofsubjectsforwhichinformation
was available on Tanner stage and socioeconomic status.
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results were analyzed in the subset of subjects with available
information on socioeconomic status and puberty followed by
adjustment for these variables (Supplemental Table S3).
ThechangeindirectionofassociationbetweeninsulinandPC/
BMCC according to method of adjustment suggests this
relationship involves a combination of direct effects and indirect
effects secondary to changes in body composition. To explore
Table 1. Characteristics of the 1344 Boys and 1440 Girls Included in the Study
a
Mean (SD) 25th centile 50th centile 75th centile
Age (years) Boys 15.47 (0.3) 15.3 15.4 15.6
Girls 15.48 (0.3) 15.3 15.4 15.6
Insulin (IU/mL) Boys 9.07 (5.3) 6.1 8.1 10.9
Girls 10.62 (5.4) 7.4 9.7 12.8
Height (cm) Boys 174.73 (7.6) 170 175 179.8
Girls 164.77 (6.1) 161 164.6 168.7
Weight (kg) Boys 64.05 (11.3) 56.8 62.6 69.8
Girls 59.35 (10.4) 52.3 57.7 64.5
BMI (kg/m
2) Boys 20.91 (3.0) 18.9 20.3 22.2
Girls 21.84 (3.5) 19.4 21.2 23.4
MCSA (mm
2) Boys 5538.45 (1051.8) 4809.8 5459.3 6192.5
Girls 5001.25 (893.9) 4386.4 4938.6 5575.5
SAT (mm
2) Boys 2053.33 (726.2) 1567 1906.4 2378.4
Girls 2913.39 (826.1) 2332.8 2789.5 3356
MD (mg/cm
3) Boys 85.36 (4.7) 82.4 84.4 87.3
Girls 85.17 (5.0) 81.8 84 87.1
PC (mm) Boys 76.42 (5.3) 72.9 76.3 79.7
Girls 69.55 (4.8) 66.2 69.2 72.6
EC (mm) Boys 40.9 (5.6) 37.3 40.6 44
Girls 36.88 (5.1) 33.5 36.3 39.6
BMDC (mg/cm
3) Boys 1077.13 (33.2) 1056.7 1078.9 1101.5
Girls 1124.61 (22.6) 1110.9 1125.9 1139.8
BMCC (mg/mm) Boys 357.1 (52.1) 321.8 356.1 388.9
Girls 310.86 (41.0) 282.5 310.1 338.2
SSI (mm
3) Boys 1172.24 (231.6) 1011.1 1159.2 1324
Girls 925.39 (179.5) 798.5 904.7 1040.3
SD¼standard deviation; BMI¼body mass index; MCSA¼muscle cross-sectional area; SAT¼subcutaneous fat area; MD¼muscle density; PC¼
periosteal circumference; EC¼endosteal circumference; BMDC¼cortical bone density; BMCC¼cortical bone mineral content; SSI¼strength strain index.
aPeripheral quantitative computed tomography (pQCT)-derived variables obtained at the mid-tibia.
Table 2. Associations Between Fasting Insulin and Body Composition Variables Derived From Tibial pQCT in 1344 Boys and 1440 Girls
Outcome Adjusted
a Sex Beta
b (95% CI) p Value p Value(Sex Dif.)
Height Age Boys 0.010 ( 0.006, 0.027) 0.2276 0.5397
Girls 0.002 ( 0.015, 0.021) 0.7805
All 0.007 ( 0.005, 0.019) 0.2601
MCSA HeightþAge Boys 0.033 (0.014, 0.052) 0.0007 0.2405
Girls 0.050 (0.029, 0.071) 0.0001
All 0.041 (0.027, 0.055) 0.0001
SAT HeightþAge Boys 0.094 (0.078, 0.110) 0.0001 0.0505
Girls 0.070 (0.052, 0.088) 0.0001
All 0.083 (0.071, 0.095) 0.0001
MD MCSAþHeightþAge Boys  0.023 ( 0.034,  0.013) 0.0001 0.0929
Girls  0.010 ( 0.021, 0.001) 0.0844
All  0.017 ( 0.025,  0.010) 0.0001
pQCT¼peripheral quantitative computed tomography; CI¼confidence interval; MCSA¼muscle cross-sectional area; SAT¼subcutaneous fat area;
MD¼muscle density.
aCovariates used for each model.
bBeta coefficients represent standard deviation change in the outcome variable per 50% increase in fasting insulin.
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effect of insulin on PC via a direct pathway independent of body
composition and via SAT, muscle density, and MCSA. In analyses
based on boys and girls combined, there was an inverse
association between insulin and PC via a direct pathway and an
inverse association between insulin and PC via muscle density
(Fig. 2). In contrast, there were positive associations between
insulin and PCinvolving SAT and MCSA pathways. Infurther path
analyses based on boys and girls separately, the inverse
association between insulin and PC via a direct pathway
appeared to be stronger in boys, whereas the positive
association between insulin and PC via MCSA tended to be
stronger in girls (Fig. 3). Consequently, whereas there was a net
positive association between insulin and PC in girls, no net effect
was seen in boys.
Discussion
We performed a cross-sectional analysis of the relationship
between insulin levels and pQCT parameters as assessed at the
mid-tibia in 2784 boys and girls mean 15.5 years of age. We
found that insulin was positively related to tibial BMCC in
minimally adjusted models, which is likely to reflect an influence
Table 3. Associations Between Insulin and 50% Mid-Tibia Cortical Bone Variables
a
Outcome Adjusted
b Sex Beta
c (95% CI) p Value pV alue (Sex Dif.)
PC Age Boys 0.009 ( 0.008, 0.025) 0.3029 0.2687
Girls 0.023 (0.004, 0.041) 0.0141
All 0.015 (0.003, 0.027) 0.0152
Age, Height, MCSA, SAT, MD Boys  0.017 ( 0.029,  0.004) 0.0119 0.3911
Girls  0.008 ( 0.022, 0.006) 0.2390
All  0.013 ( 0.022,  0.003) 0.0077
EC PC, Age Boys 0.000 ( 0.013, 0.014) 0.9897 0.3776
Girls  0.009 ( 0.024, 0.006) 0.2351
All  0.004 ( 0.014, 0.006) 0.4463
PC, Age, Height, MCSA, SAT, MD Boys 0.001 ( 0.013, 0.014) 0.9190 0.6003
Girls  0.004 ( 0.019, 0.010) 0.5341
All  0.001 ( 0.011, 0.009) 0.7953
BMDC Age Boys  0.025 ( 0.041,  0.009) 0.0023 0.2673
Girls  0.011 ( 0.028, 0.006) 0.1933
All  0.018 ( 0.030,  0.006) 0.0023
Age, Height, MCSA, SAT, MD Boys  0.024 ( 0.040,  0.008) 0.0035 0.2769
Girls  0.011 ( 0.028, 0.006) 0.2138
All  0.018 ( 0.030,  0.006) 0.0026
BMDC PC, EC, Age Boys  0.024 ( 0.039,  0.009) 0.0018 0.2073
Girls  0.010 ( 0.026, 0.006) 0.2459
All  0.017 ( 0.028,  0.006) 0.0020
PC, EC, Age, Height, MCSA, SAT, MD Boys  0.030 ( 0.045,  0.014) 0.0001 0.1997
Girls  0.015 ( 0.031, 0.001) 0.0687
All  0.023 ( 0.034,  0.012) 0.0001
BMCC Age Boys 0.003 ( 0.015, 0.021) 0.7286 0.1757
Girls 0.021 (0.002, 0.041) 0.0306
All 0.012 ( 0.002, 0.025) 0.0821
Age, Height, MCSA, SAT, MD Boys  0.018 ( 0.032,  0.003) 0.0156 0.2575
Girls  0.006 ( 0.021, 0.010) 0.4772
All  0.013 ( 0.024,  0.002) 0.0197
SSI Age Boys 0.006 ( 0.011, 0.024) 0.4695 0.2238
Girls 0.022 (0.003, 0.041) 0.0203
All 0.014 (0.001, 0.026) 0.0331
Age, Height, MCSA, SAT, MD Boys  0.020 ( 0.033,  0.007) 0.0021 0.1829
Girls  0.007 ( 0.021, 0.006) 0.2932
All  0.015 ( 0.024,  0.005) 0.0026
MSCA¼muscle cross sectional area; SAT¼subcutaneous fat area; MD¼muscle density; PC¼periosteal circumference; EC¼endosteal circumference;
BMDC¼cortical bone density; BMCC¼cortical bone mineral content; SSI¼ strength strain index.
aAssociations between fasting insulin and cortical bone parameters derived from tibial pQCT, in 1344 boys and 1440 girls.
bCovariates used for each model are listed under adjusted.
cBeta coefficients represent SD change in the outcome variable per 50% increase in fasting insulin.
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was observed with tibial PC. However, the positive relationship
between insulin levels and PC in minimally adjusted analyses
appears to be confounded by associations with fat and lean
mass because an inverse association was observed after
adjusting for these. There was also evidence for an inverse
pathway between insulin and PC via intramuscular fat as
reflected by muscle density, but pathway analyses suggested
that this was relatively weak, and an inverse association between
insulin and PC was still observed after adjustment for all body
composition variables including muscle density. In addition,
insulin levels were inversely related to BMDC in both minimally
and more completely adjusted analyses, consistent with our
previous observation that unlike PC, BMDC only shows very weak
relationships with fat mass and lean mass.
(16)
Presumably, the suggestion of positive confounding of the
relationship between insulin and PC by body composition is
explained by associations between body composition and both
insulin and PC. For example, we observed a positive association
between insulin and tibial MSCA and SAT, in line with previous
findings that insulin levels are positively related to indices of
body composition including in adolescents.
(24) Moreover, we
recently reported that equivalent estimates of these body
composition parameters assessed by total body DXA have
strong positive relationships with tibial PC.
(16) Subsequent path
analyses indicated that broadly effects via muscle and fat
contribute equally to this indirect positive effect of insulin on PC
via body composition. Conversely, any evidence that negative
confounding by intramuscular fat as reflected by muscle density
contributed to the relationship between insulin and PC is
explained by an inverse relationship between insulin and muscle
density, combined with a positive association between muscle
density and PC (Figs. 2 and 3).
BecausePCandBMDCbothrepresentpositivedeterminantsof
bone mass as measured by DXA, our findings are consistent with
previous reports that after adjustment for BMI, BMD and/or BMC
as measured by DXA is reduced in subjects with elevated insulin
levels secondary to insulin resistance in the context of the
metabolic syndrome, including adolescents and prepubertal
children.
(5–9,25) In the majority of these studies, inverse
associations between insulin and BMD after adjusting for BMI
appeared to be stronger in males, which also applied to our
findings of associations between insulin and both PC and BMCC.
In addition, our results are consistent with previous pQCT-based
studies in older adults with raised insulin levels in the context of
type 2 DM, in whom cortical bone size was reduced after
adjusting for BMI/weight,
(26,27) consistent with a reduction in PC.
Interestingly, a recent high-resolution pQCT study in type 2 DM
suggested that this condition is also associated with an increase
incortical porosity,
(28) suggesting that the inverse association we
observed between insulin and BMDC may be secondary to an
increase in cortical bone turnover.
Taken with results of previous studies based in adult
populations, our findings suggest that raised insulin levels are
associated with a negative influence on cortical bone when
associated changes in body composition are taken into account,
whichcan manifest inchildhood and maypersist throughout the
remainderofthelifecourse.Therefore,itistemptingtospeculate
that the inverse association between insulin levels and cortical
bone parameters that we observed after adjusting for fat mass,
lean mass, and muscle density contribute to the increase in
fracture risk described in older patients with type 2 DM.
(2)
Interestingly, this increased risk appears to be greatest for
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Fig. 3. Path diagram depicting relationships between fasting insulin and
periosteal circumference (PC) in (A) 1344 boys and (B) 1440 girls. The
model is constrained to show the effects via muscle cross-sectional area
(MSCA), muscle density, subcutaneous fat area (SAT), and a ‘‘direct’’
pathway after adjusting for body composition. Solid lines depict positive
effects and broken lines depict negative effects. The thickness of the line
represents the strength of each pathway, reflected by beta (b) estimates,
which were derived from regressions between fasting insulin and indices
of body composition as shown in Table 2 and between indices of body
composition andPC. Boys: MCSAversusPC, beta¼0.161 (95%CI0.142 to
0.18); SAT versus PC, beta¼0.034 (95% CI 0.019 to 0.049); muscle density
versus PC, beta¼0.02 (95% CI  0.004 to 0.044). Girls: MCSA versus PC,
beta¼0.191 (95% CI 0.17 to 0.212); SAT versus PC, beta¼0.053 (95% CI
0.035 to 0.071); muscle density versus PC, beta¼0.03 (95% CI 0.002 to
0.057).
Insulin
MCSA P<0.0001 
β 0.015 (95% CI: 0.010, 0.020) 
Direct: P=0.0108 
β -0.012 (95% CI: -0.022, -0.003) 
Muscle Density P=0.0004 
β -0.002 (95% CI: -0.004, -0.001) 
PC
SAT P<0.0001 
β 0.013 (95% CI: 0.009, 0.016) 
Total Effects P=0.0222 
β 0.013 
(95% CI: 0.002, 0.024) 
Positive Association  Negative Association 
Fig. 2. Path diagram depicting relationships between fasting insulin and
periosteal circumference (PC) in 1344 boys and 1440 girls combined. The
model is constrained to show the effects via muscle cross-sectional area
(MSCA), muscle density, subcutaneous fat area (SAT), and a ‘‘direct’’
pathway after adjusting for body composition. Solid lines depict positive
effects and broken lines depict negative effects. The thickness of the line
represents the strength of each pathway, reflected by beta (b) estimates,
which were derived from regressions between fasting insulin and indices
of body composition as shown in Table 2 and between indices of body
composition and PC as follows: MCSA versus PC, beta¼0.175 (95% CI
0.161 to 0.189); SAT versus PC, beta¼0.043 (95% CI 0.031 to 0.054);
muscle density versus PC, beta¼0.025 (95% CI 0.007 to 0.043).
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(29,30) consistent with our
results based on pQCT of the tibia. The suggestion that any
adverse influence of insulin on fracture risk is largely indepen-
dent of intramuscular fat is also consistent with findings from a
study of older subjects with type 2 DM, in whom the observed
increase in fracture risk was not attenuated by adjustment for
intramuscular fat as assessed by CT.
(31)
The current findings are based on analysis of fasting insulin,
rather than an index of insulin resistance such as homeostasis
model assessment of insulin resistance (HOMA-IR), which
might have more relevance to type 2 DM in which insulin
resistance is the cardinal feature. However, glucose levels are
tightly controlled in childhood, and fasting insulin is highly
correlated with HOMA-IR (as confirmed by a bivariate Pearson
correlation of r¼0.98 between fasting insulin and HOMA-IR in
the currentstudy population),so HOMA-IRisnotthought tooffer
any advantages in evaluating insulin resistance in children.
(32)
In terms of the mechanisms underlying the apparent adverse
effect of insulin on cortical bone suggested by our results, if
anything, insulin and related hormones such as insulin-like
growth factor 1 are thought to exert a trophic effect on the
skeleton.
(33,34) Therefore, any adverse influence of insulin on
cortical bone growth is likely to reflect a role of other factors
associated with raised insulin levels rather than a direct action of
insulin itself. One such candidate is adiponectin, which is
inversely related to insulin resistance, but we recently observed
an inverse association between this factor and cortical bone area
in ALSPAC, suggesting that if anything, this pathway contributes
a positive rather than negative influence.
(35) Another potential
pathway is between insulin and osteocalcin, in light of animal
studies that suggest that osteoblast-derived uncarboxylated
osteocalcin acts to improve insulin sensitivity,
(36,37) which has
been confirmed in studies in childhood in which uncarboxylated
osteocalcin levels were found to be lower in those with
prediabetes/insulin resistance.
(38) However, to the extent that a
relationship exists between bone and energy metabolism, how
reduced levels of uncarboxylated osteocalcin in the context of
hyperinsulinemia might affect osteoblast function and cortical
bone growth or turnover is currently unclear.
Limitations
Given its cross-sectional design, it is difficult to infer causal
relationships between the biological variables investigated.
Moreover, our results are solely reliant on pQCT measurements
obtainedatasinglesite,namelythemid-tibia.Inapreviousstudy
of relationships between obesity and pQCT outcomes, a positive
relationship was observed between fat mass and cortical bone
measures at the tibia but not the radius;
(39) if related factors
such as insulin also vary in terms of relationships with cortical
bone indices of the upper and lower limb, it may be that our
results are only applicable to lower limb development.
Furthermore, we were unable to examine relationships with
trabecular bone, which represents a limitation in light of
evidence that type 2 DM may be associated with increased
trabecular BMD.
(28) However, in a further study in ALSPAC, we
observed an equivalent inverse association between fasting
insulin and total body BMD as measured by DXA after adjusting
for fat and lean mass, suggesting that the relationship described
here based on tibial pQCT is representative of associations
between fasting insulin and bone development in the skeleton
as a whole (our unpublished observations). Finally, we only had
limited information on potentially important confounders such
aspuberty,whichwasassessedbyself-completionquestionnaire
as opposed to more direct clinical evaluation.
Final conclusions
In conclusion, we have found that, after accounting for
associated differences in body composition, insulin levels are
inversely related to both tibial PC and BMDC. Although insulin
levels were positively associated with intramuscular fat deposi-
tion as reflected by muscle density, consistent with a possible
lipotoxic pathway, the inverse relationship between insulin
and cortical bone parameters persisted after adjusting for both
subcutaneous and intramuscular fat. Further investigation is
justified to clarify the mechanisms underlying this apparent
negative influence of insulin on cortical bone development
because any tendency for insulin to impair cortical bone
developmentmayhaveimportantclinicalconsequences,suchas
contributing to the excess in fracture risk observed in conditions
associated with hyperinsulinemia such as type 2 DM.
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